Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
Go back to Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026| (NASDAQ: RLMD) | Delayed: 4.43 +0.06 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.37 | 52 Week High | $4.10 | |||
| Open | $4.35 | 52 Week Low | $0.87 | |||
| Day High | $4.44 | P/E | N/A | |||
| Day Low | $4.32 | EPS | $0.00 | |||
| Volume | 675,556 | |||||

